NewsCritics Say FDA’s Use of Surrogate Markers Falling Short admin1 year ago01 mins Source link Post Views: 46 Post navigation Previous: CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy DrugNext: Antibiotic overuse linked to poor record-keeping in healthcare settings